Home › Breast Cancer › Illinois › Cicero
Breast Cancer clinical trials in Cicero, IL
11 studies for Breast Cancer are looking for participants at sites in and around Cicero (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
RecruitingPhase 3
- Hope And Healing Care, Hinsdale · 10 mi away
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- OSF Little Company of Mary Medical Center, Evergreen Park · 9 mi away
- Advocate Christ Medical Center, Oak Lawn · 9 mi away
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RecruitingPhase 3
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · 3 mi away
- Loyola University Medical Center, Maywood · 5 mi away
- Marjorie Weinberg Cancer Center at Loyola-Gottlieb, Melrose Park · 7 mi away
- and 6 more
E-Mindfulness Approaches for Living After Breast Cancer
RecruitingPhase 3
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · 3 mi away
- Loyola University Medical Center, Maywood · 5 mi away
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi away
- and 1 more
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RecruitingPhase 2
- Loyola University, Maywood · 5 mi away
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RecruitingPhase 3
- Loyola University Medical Center, Maywood · 5 mi away
- Advocate Christ Medical Center, Oak Lawn · 9 mi away
- Elmhurst Memorial Hospital, Elmhurst · 10 mi away
- and 1 more
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
RecruitingPhase 1/2
- Hope and Healing Cancer Services, Hinsdale · 10 mi away
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecruitingObservational study
- Advocate Christ Medical Center, Oak Lawn · 9 mi away
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · 9 mi away
- Advocate High Tech Medical Park, Palos Heights · 12 mi away
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
RecruitingPhase 3
- Loyola University Medical Center, Maywood · 5 mi away
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
RecruitingObservational study
- Affiliated Oncologists, Oak Lawn · 9 mi away
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
Recruiting
- Loyola University, Maywood · 5 mi away
About Breast Cancer
Breast cancer is a cancer that starts in the breast tissue, when cells change and grow out of control. These extra cells can form a mass called a tumor.
More about Breast Cancer on MedlinePlus
Breast Cancer trials in other cities
- New York City, NY134 studies
- Houston, TX126 studies
- Boston, MA111 studies
- Nashville, TN80 studies
- Los Angeles, CA72 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Durham, NC63 studies
- Queens, NY63 studies
- Chicago, IL58 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Other studies in Cicero
- Non-Small Cell Lung Cancer24 studies
- Lung Cancer17 studies
- Prostate Cancer14 studies
- Cancer (all types)13 studies
- Acute Myeloid Leukemia11 studies
- Colorectal Cancer10 studies
- Bladder Cancer8 studies
- Metastatic Cancer7 studies
- Melanoma7 studies
- Cardiovascular Disease7 studies
- Burkitt Lymphoma6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.